Satellos Bioscience MSLE Income Statement (2023-2026)

NASDAQ MSLE
$10.19 +0.10 (+0.94%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2023 Dec2024 Mar2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 112.79M9.56M13.82M15.46M18.44M
Operating items
Research & Development (Quarter) 4.54M7.31M
Selling, General & Administrative (Quarter) 1.94M2.73M
Operating Expenses (Quarter) 6.48M10.04M
EBIT (Quarter) 6.08M-9.73M
Non-operating items
Interest & Investment Income (Quarter) 0.39M0.42M
Other Non Operating Income (Quarter) 0.01M-0.11M
Net income details
EBT (Quarter) 6.08M-9.73M
Tax Provisions (Quarter) 0.06M-0.03M
Profit After Tax (Quarter) 6.14M-9.77M
Income from Continuing Operations (Quarter) 6.01M-9.70M
Consolidated Net Income (Quarter) 6.01M-9.70M
Income towards Parent Company (Quarter) 6.01M-9.70M
Net Income towards Common Stockholders (Quarter) 6.01M-9.70M
Additional items
EPS (Basic) (Quarter) 0.44-0.53
EPS (Diluted) (Quarter) 0.63-0.66
Shares Outstanding (Quarter) 9.56M13.82M14.60M18.44M
Shares Outstanding (Diluted) (Quarter) 9.56M9.56M14.60M14.60M
EBITDA (Quarter) 6.08M-9.73M
Tax Rate (Quarter) 1.040.34